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We present evidence for multiple independent origins of recombinant SARS-CoV-2 viruses sampled 19 
from late 2020 and early 2021 in the United Kingdom. Their genomes carry single nucleotide 20 
polymorphisms and deletions that are characteristic of the B.1.1.7 variant of concern, but lack the full 21 
complement of lineage-defining mutations. Instead, the remainder of their genomes share contiguous 22 
genetic variation with non-B.1.1.7 viruses circulating in the same geographic area at the same time as 23 
the recombinants. In four instances there was evidence for onward transmission of a recombinant-24 
origin virus, including one transmission cluster of 45 sequenced cases over the course of two months. 25 
The inferred genomic locations of recombination breakpoints suggest that every community-26 
transmitted recombinant virus inherited its spike region from a B.1.1.7 parental virus, consistent with 27 
a transmission advantage for B.1.1.7’s set of mutations.  28 
 29 
 30 
Key Words 31 




Recombination, the transfer of genetic information between molecules derived from different 36 
organisms, is a fundamental process in evolution because it can generate novel genetic variation upon 37 
which selection can act (Felsenstein, 1974). Genetic analysis indicates that recombination occurs 38 
frequently in betacoronaviruses (Lai et al., 1985; Keck et al., 1988; Lai and Cavanagh, 1997), 39 
including natural populations of MERS-CoV (Corman et al., 2014; Dudas and Rambaut, 2016; Kim et 40 
al., 2016) and SARS and SARS-like coronaviruses (Hon et al., 2008; Boni et al., 2020). The zoonotic 41 
transmission of an alphacoronavirus whose spike gene shows evidence of being the product of 42 
recombination between feline and canine coronaviruses has occurred in Malaysia, which demonstrates 43 








has been proposed recently that the global SARS-CoV-2 genome sequence data contains signals of 45 
recombination across the pandemic (VanInsberghe et al., 2021). Recombination has the potential to be 46 
important in the context of pathogen evolution because it can “rescue” genomes with otherwise 47 
deleterious mutations or provide the opportunity to create novel phenotypes by bringing genetic 48 
variation from different backgrounds onto a single genome. A concerning scenario from an 49 
epidemiological perspective is the potential for recombination to combine, in the same genome, 50 
mutations that may confer immune-escape properties with those that may enhance transmissibility. 51 
Enhanced transmissibility (Volz et al., 2021) and immune-escape (Planas et al., 2021) phenotypes 52 
have already been observed in SARS-CoV-2. Consequently, the characterization of recombination in 53 
SARS-CoV-2 is important for surveillance purposes. 54 
 55 
The molecular mechanism of homologous recombination in unsegmented positive-sense RNA viruses 56 
such as SARS-CoV-2 is generally by copy-choice replication, a model first suggested in poliovirus 57 
(Cooper et al., 1974). In this process a hybrid or mosaic RNA is formed when the RNA-polymerase 58 
complex switches from one RNA template molecule to another during replication (Worobey and 59 
Holmes, 1999). In order for homologous recombination to occur, and be subsequently detected, there 60 
must be co-infection of the same cell within an individual by genetically-distinct viruses (termed the 61 
‘parental’ lineages of the recombinant virus). Co-infection of an individual requires there to be co-62 
circulation of multiple viral lineages within a population and, given the short duration of most SARS-63 
CoV-2 infections, is most likely to be observed when virus prevalence is high. 64 
 65 
Conditions conducive to SARS-CoV-2 recombination existed in the United Kingdom (UK) during the 66 
latter part of 2020 and early in 2021. From mid-October 2020 to January 2021, SARS-CoV-2 67 
prevalence was estimated to be between 1 and 2% in England (Steel and Hill, 2021). During this time, 68 
the B.1.1.7 variant of concern (VOC), which is also referred to as Alpha under the World Health 69 
Organisation nomenclature (WHO, 2021), emerged, rapidly increased in frequency, and spread across 70 
the UK, replacing lineages that were already at high prevalence (Volz et al., 2021). The most common 71 








characterised by an unusually large number of genetic changes (22 mutations from its immediate 73 
ancestor; Rambaut et al., 2020). The ability to detect virus recombination using comparative sequence 74 
analysis depends on the genetic distinctiveness of the parental viruses, so the co-circulation of B.1.1.7 75 
and non-B.1.1.7 viruses is expected to increase the power to detect recombinants between these 76 
lineages. The UK’s high rate of genomic surveillance and unified collection of genomic, 77 
epidemiological, and geographic data also provide multiple lines of evidence for evaluating the 78 
identification of recombinant viruses. 79 
 80 
To identify putative SARS-CoV-2 recombinant viruses we carried out an analysis of all complete UK 81 
SARS-CoV-2 genomes that had been assigned to lineage B.1.1.7 and which showed evidence of being 82 
the product of combining different genetic lineages, indicative of recombination. Specifically, we 83 
scanned the UK dataset for genomes that were alternately composed of long contiguous tracts of 84 
B.1.1.7 and non-B.1.1.7 genetic variation. The genetic composition and epidemiological context of 85 
each candidate mosaic genome was carefully explored to determine whether it was recombinant in 86 
origin. We subsequently determined whether the recombinants showed evidence of onward 87 
transmission within the UK population. One recombinant lineage continued to circulate for at least 88 





Identification of putative recombinants 94 
We identified a total of 16 recombinant sequences from the whole UK dataset of 279,000 sequences 95 
up to the 7th March 2021, using our bioinformatic and evolutionary analysis pipeline (see Methods). 96 
Twelve genome sequences that clustered into four groups (labelled A - D) and four additional 97 
singletons showed evidence of being mosaic in structure (Table 1; Supplementary Table S1). For each 98 








the UK (Table 1). For Group A, which spanned two geographical regions, all the samples originated 100 
from close to the border between Wales and the North-West of England (<20km apart). The sample 101 
dates for the putative recombinants ranged from 2020/12/18 - 2021/02/02 (Figure 1). If Groups A-D 102 
represent community transmission of a recombinant lineage with a single origin, recombination must 103 
have occurred on or before the date of the earliest sample in each group. It is possible to use molecular 104 
clock dating to infer bounds on recombination events, but given uncertainties in the rate of the 105 
molecular clock, estimates from such methods have large confidence intervals (Raghwani, Thomas 106 
and Koekkoek, 2012). Because our dataset consists of high-density genomic sampling covering the 107 
time period over which we infer recombination to have occurred, we use the earliest sample dates 108 
described above as representative of the approximate time of the recombination events. The range of 109 
dates coincides with a period of increasing relative prevalence of B.1.1.7 in the UK alongside the 110 
presence of other circulating lineages in the community, the most common of which were B.1.177 and 111 
its descendants (Figure 1).  112 
 113 
To rule out the possibility that any of the sixteen recombinants could have resulted from artefacts as a 114 
result of assembling sequence reads from a co-infected sample (generated through either natural co-115 
infection or laboratory contamination), we examined the read coverage and minor allele frequencies 116 
and assessed the likelihood of a mixed sample. Several lines of evidence suggested the recombinant 117 
sequences were not the products of sequencing a mixture of genomes: Firstly, the sequencing protocol 118 
used in the UK (Tyson et al., 2020) generates 98 short (~350bp) amplicons, such that long tracts that 119 
match just one lineage would be unlikely. Secondly, the read data do not support a mixture for any of 120 
the putative recombinant genomes. All the recombinants were sequenced to high coverage (lowest 121 
mean read depth per site per genome: 686; highest mean read depth: 2903). The mean minor allele 122 
frequency (MAF) for the putative recombinants was 0.008, which is 6 standard deviations below the 123 
mean of the MAF (0.34) for a set of 20 sequences that we suspected to be mixtures (Supplementary 124 
Figure S1). Finally, for all groups A-D, multiple genomes with the same mosaic structure were 125 
sequenced independently from different samples, and by different sequencing centres in the case of 126 








recombinant had occurred. All of the read data are available on the European Nucleotide Archive. 128 
Accession numbers are given in Supplementary Table S2. 129 
 130 
Epidemiological information supports the identification of putative parental lineages 131 
The nucleotide variation for the putative recombinants and their closest neighbours by genetic 132 
similarity (for each of the regions of their genomes either side of the recombination breakpoint) is 133 
shown in Figure 2 and Supplementary Figure S2. For each of Groups A-D, the closest neighbours by 134 
genetic similarity for each of the two non-recombining genome regions were the same sequences for 135 
every putative recombinant within a group. For most of the recombinants, there were several 136 
equidistant putative parental sequences for each region of the genome; whenever this was true, they 137 
all belonged to the same lineage, except for Group C, whose putative parental lineages for the non-138 
B.1.1.7-like region of the genome were a mixture of two closely related lineages (B.1.221.1 and 139 
B.1.221.2). The putative parental sequence for the non-B.1.1.7 region of the genome varied by group 140 
(Table 1). Importantly, in each case, the sequence and epidemiological data demonstrate that the non-141 
B.1.1.7 parental sequence was circulating in the same geographic area as the recombinant in the time 142 
immediately before the sampling date of the recombinant. For Group A and the four singletons, the 143 
second parental sequence was assigned lineage B.1.177 or one of its descendants. B.1.177, which 144 
likely arose in Spain in the summer of 2020 and was exported to multiple European countries 145 
(Hodcroft et al., 2021), rose to high relative frequency in the UK through Autumn 2020, and was 146 
widespread by December (Figure 1). Lineage B.1.177.16, the second parental sequence of MILK-147 
103C712, was sampled 25 times in Greater London in the four weeks preceding MILK-103C712’s 148 
sample date. Lineage B.1.177.9 was sampled on one other occasion in Scotland in four weeks 149 
preceding QEUH-1067DEF’s sample date. Lineage B.1.36.28 was not sampled in the South-East of 150 
England in the four weeks preceding Group B’s sample date, but was sampled eight times in Greater 151 
London in that period. Lineages B.1.221.1 and B.1.221.2 were sampled seven and zero times, 152 
respectively, in the East Midlands in the four weeks preceding Group C’s sample date, and B.1.36.17 153 
was sampled five times in the South East in the four weeks prior to Group D’s sample date. The 154 








recombinants (Groups A-D and the four singletons) for the four weeks immediately preceding the 156 
date of the earliest sampled genome in each case are shown in Supplementary Figure S3. 157 
 158 
Putative recombinants exhibit significant mosaicism 159 
We rejected the null hypothesis of non-reticulate evolution for 14 out of the 16 putative recombinant 160 
sequences by testing these sequences for mosaicism (3SEQ (Lam, Ratmann and Boni, 2018) with 161 
Dunn-Sidak correction for multiple comparisons) against a background set of 2000 sequences 162 
randomly drawn from the course of the UK epidemic (Table 2). The lineages identified as the putative 163 
parentals assigned by 3SEQ agreed with the lineages for putative parentals assigned by genetic 164 
similarity (Tables 1 and 2) even though of the 16 closest neighbours by genetic similarity described 165 
above, none were present in the background sequence set of candidate parentals used in the 3SEQ 166 
analysis. The breakpoints reported by 3SEQ also agreed with breakpoints inferred from the 167 
distribution of Single Nucleotide Polymorphisms (SNPs) and deletions in the putative recombinants 168 
and their neighbours by genetic similarity (Tables 1 and 2). The two sequences that belong to Group 169 
B did not show a statistically significant mosaic signal of non-reticulate evolution, but 3SEQ’s Δm,n,2 170 
statistic for these two candidate recombinants showed the greatest support for mosaicism possible 171 
among the ancestry-informative polymorphic sites with their closest neighbours by genetic similarity 172 
as parentals: n = 6, m = 42, k = 42. The associated uncorrected p-value of 5.7e-7 does not survive a 173 
multiple comparisons correction due to the number of putative parental lineages and descendants that 174 
were tested (Table 2) 175 
 176 
The Dunn-Sidak correction used in 3SEQ is very conservative as it assumes that all 64.0 million 177 
comparisons we performed are independent statistical tests, when in fact these tests are highly non-178 
independent since many candidate parental sequences are a small number of nucleotide differences 179 
apart from each other. When corrected p-values are borderline, the recommended approach to infer 180 
non-reticulate evolution is to build separate phylogenetic trees for the non-recombining regions of the 181 
genome to confirm that the recombinant in question has different phylogenetic placements in different 182 








whose placement within B.1.177 was not well supported, each recombinant’s two phylogenetic 184 
placements were with the lineages that we identified as parental by genetic similarity and by using 185 
3SEQ, with high bootstrap support (Supplementary Table S3). The placement of the two parental 186 
genome regions for each recombinant in the context of the whole epidemic in the UK is shown in 187 
Figure 3.  188 
 189 
The mosaic structures of the genomes of the putative recombinants are shown in Figure 4. In six out 190 
of eight instances (and all four of the groups of >1 sequence, which may represent community 191 
transmission), the recombinants contain a spike gene from the B.1.1.7 lineage. In four instances there 192 
is a proposed recombination breakpoint at or near the 5’ end of the spike gene. 193 
 194 
Further evidence for the community transmission of Group A 195 
A follow-up investigation of the eight sets of putative recombinants (Groups A-D and the four 196 
singletons) on 5th May 2021 found 41 sequences that were descended from Group A (Figure 5). No 197 
descendants from any other recombinant event were detected to have continued to circulate. The 41 198 
sequences share the same set of SNPs with three members of Group A (ALDP-11CF93B, ALDP-199 
125C4D7 and LIVE-DFCFFE), with additional nucleotide variation at positions 8090, 16260 and 200 
25521 (Figure 5A; Supplementary Figure 4). They were sampled in the North West of England, 201 
between 2021/03/01 and 2021/04/04 (Figure 5B;C). The temporal distribution of samples descended 202 
from the recombination event that led to Group A suggests that the recombinant lineage persisted at 203 
low frequency for a period of time before expanding and then contracting again (Figure 5C). A second 204 
follow-up investigation on 14
th
 July 2021 found no further recombinants descended from Group A, 205 
which suggests that this transmission cluster is extinct. The dynamics of this cluster of infections 206 
reflect the wider trend of SARS-CoV-2 prevalence in England over the same time period. Prevalence 207 
decreased from a maximum of 2.08% in January 2021 to 0.21% for the week beginning 2021/04/04 208 
and to <0.1% as of the beginning of May, 2021 (Steel and Hill, 2021). Group A and its descendants 209 
met the criteria for designation as a recombinant Pango lineage (Pybus, 2021), and have been named 210 











Here we report the first unambiguous detection and characterisation of the arisal and subsequent 215 
community-transmission of recombinant SARS-CoV-2 viruses. Comparison of intra-genomic 216 
variation, supported by geographic and epidemiological data, demonstrates the occurrence of multiple 217 
independent recombination events involving UK virus lineages in late 2020. Recombinant genomes 218 
that share genetic identity were sampled from the same geographic location and time period, 219 
indicating they represent successful onward transmission after the occurrence of a single ancestral 220 
recombination event. In one instance this resulted in a significant transmission cluster comprising 45 221 
observed cases, which has been given the Pango lineage name XA. While no obvious biological 222 
advantage can be attributed to this cluster (or to any of the observed recombinants) beyond the 223 
acquisition of B.1.1.7’s set of spike mutations, these recombinants are sentinel events for continued 224 
monitoring for new variants. With the increasing co-circulation of variants of concern in the same 225 
geographic areas careful monitoring is warranted. 226 
 227 
Large-scale bioinformatic approaches have identified statistical signals of recombination among 228 
SARS-CoV-2 sequences, using clade assignment and its changes along the genome as the primary 229 
characteristic under investigation (Varabyou et al., 2020; VanInsberghe et al., 2021). Due to the 230 
limited genetic diversity at the time these analyses were carried out, there was no strong statistical 231 
support for recombination (as opposed to non-reticulate diversification) for any particular candidate 232 
recombinant. When the number of mutations in a virus sequence is low (e.g. Figure 3 in VanInsberghe 233 
et al., (2021); Figure 2 in Varabyou et al., (2020)) there is generally little statistical support to reject 234 
the possibility that the sequence patterns could have been generated by mutation alone. In contrast, 235 
there is sufficient diversity in the UK virus dataset between the lineage B.1.1.7 and other co-236 
circulating lineages to detect putative recombinants and demonstrate statistical significance for their 237 







nucleotide mutations apart; and candidate pairs of parentals are a median of 46 nucleotide differences 239 
apart from each other (Figure 2, Supplementary Figure S2). The p-values we present are exact non-240 
parametric probabilities that the observed patterns of nucleotide ancestry in the candidate recombinant 241 
viruses were generated by mutation alone given the parental genotypes, and are corrected for multiple 242 
testing. 243 
 244 
The breakpoint locations inferred from the recombinants’ parental lineages by two different methods 245 
and two different parental datasets are in agreement (cf. Tables 1; 2). Two interesting observations 246 
arise from their distribution. Firstly, in six cases, and in all the cases where we detected transmission, 247 
the spike gene was inherited from the B.1.1.7 parental sequence (Figure 4). This is consistent with the 248 
observed transmission advantage of B.1.1.7 (Volz et al., 2021), which is likely attributable to the 249 
mutations it carries in the spike region (Rambaut et al., 2020). Secondly, in four instances a 250 
breakpoint is located near the 5’ end of the spike gene. A defining feature of the Order Nidovirales, to 251 
which coronaviruses belong, is the production during RNA synthesis of a set of nested positive- and 252 
negative-stranded subgenomic RNAs (sgRNAs) that contain a leader sequence derived from the 5’ 253 
end of the complete genome and a progressively reduced complement of the structural (S, E, M, N) 254 
and accessory genes, which form the body of the sgRNA molecule (Masters, 2006; Kim et al., 2020). 255 
The discontinuous nature of these sgRNAs is understood to be the product of template switching by 256 
viral polymerase during normal transcription, where the polymerase pauses at a transcription-257 
regulatory sequence (TRS) after transcribing the last open reading frame (ORF) of the sgRNA, and 258 
switches to a similar TRS upstream of the leader sequence (Sawicki and Sawicki, 1995), omitting a 259 
looped-out region of the template RNA, which contains at least orf1ab in the case of SARS-CoV-2 260 
(Finkel et al., 2021). This provides an environment that is highly conducive to homologous 261 
recombination: a polymerase that engages in template switching during its normal transcriptional 262 
activity, as well as the availability of alternative template RNA molecules, in the form of sgRNAs, 263 
which incorporate sequence motifs that mediate template switching, and which might be derived from 264 
different genomes in the case of coinfection. As TRSes, which occur between the ORFs (Kim et al., 265 








coronaviruses, this can account for the shared pattern of recombination-prone regions observed here 267 
(Figure 4). However, to be detected recombinant genomes must lead to viable viruses, so the 268 
distribution of breakpoints observed from genomic surveillance may not represent the distribution of 269 
breakpoints that occur in situ (Banner and Lai, 1991). 270 
 271 
Given the overall prevalence of SARS-CoV-2 in the UK in December 2020 of 1% (Steel and Hill, 272 
2021) and assuming that 40% of infections were of lineage B.1.1.7 and 40% of B.1.177 (Figure 1), a 273 
simplistic expectation for the number of co-infections involving these two lineages is the product of 274 
their prevalences, which is 16 co-infections per million people. The figure is 70 co-infections per 275 
million people for a prevalence of 2%, 70% infection with B.1.1.7 and 25% infection with B.1.177, 276 
which applies to the first half of January 2021. In this calculation we assume that infections are 277 
independent and that once infected the chance of an additional infection occurring is unchanged. This 278 
illustrates that on a national scale, co-infection should be quite common during periods of high 279 
prevalence. From a public health perspective, this reminds us that halving prevalence reduces the 280 
chance of coinfection by a factor of four, because the probability of coinfection increases with the 281 
square of the prevalence. 282 
 283 
As recombination permits the combination of advantageous mutations from distinct variants, and 284 
recombination is only possible with co-infection, minimising the prevalence of SARS-CoV-2 will 285 
minimize the chance of forming recombinant lineages with genetic combinations that could 286 
potentially increase virus fitness. At the time of writing, the trajectory of the SARS-CoV-2 pandemic 287 
continues to remind us that there are many populations worldwide still highly susceptible to large 288 
epidemic waves. High prevalence epidemic waves comprising diverse viral lineages risk high rates of 289 
meaningful recombination, and as SARS-CoV-2 genetic diversity is much greater in 2021 than in 290 
2020, it will be important to examine each epidemic for the presence of novel recombinant lineages, 291 










Limitations of the study 295 
In the Results we discuss the possibility that the mosaic patterns of genetic variation observed in the 296 
putative recombinant genome sequences might be the product of some process other than 297 
recombination, for example the sequencing of a natural co-infection or of a mixed sample due to 298 
laboratory contamination. However, neither the distribution of the raw read allele frequencies for the 299 
putative recombinants (which are unlike those we observe in samples that we suspect to be real 300 
mixtures), nor the spatial distribution of genetic variation along their genomes (consisting of long 301 
contiguous tracts compatible with a single lineage; which is not the pattern expected for a mixture of 302 
samples given the sequencing protocol employed in the UK) suggests that this is the case. In the case 303 
of the groups A-D, the sequencing of multiple distinct samples with nearly identical genetic variation 304 
provides strong a posteriori evidence against any of these genomes being the product of sequencing a 305 
mixed sample. This strength of evidence does not exist for the four singleton genomes, so they should 306 
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Figure Legends 455 
 456 
Figure 1 457 
SARS-CoV-2 lineages in the UK, Winter 2020-2021. The distribution of the most frequent SARS-458 
CoV-2 lineages in the United Kingdom from December 2020 to February 2021. Here, B.1.177 refers 459 
to B.1.177 including all of its descendant lineages (e.g. B.1.177.9). For each recombinant, or 460 
recombinant group, the date of the earliest sampled genome is indicated by an arrowhead. The 461 
recombination event that generated each must have occurred before this date. For Groups A-D, the 462 
body of the arrow represents the range of dates that the samples span. 463 
 464 
Figure 2 465 
The nucleotide variation present in Group A. The nucleotide variation with respect to the reference 466 
sequence (MN908947.3; grey genome far bottom) for the four members of Group A (ALDP-467 
11CF93B, ALDP-125C4D7, LIVE-DFCFFE, ALDP-130BB95; middle four coloured genomes) and 468 
their closest neighbours by genetic similarity among all UK sequences from the same time period for 469 
the B.1.1.7-like region of their genomes (ALPD-12A277F; top coloured genome) and the B.1.177-like 470 
region of their genomes (ALDP-119C5F7; bottom coloured genome). See also Figure S2. 471 
 472 
Figure 3 473 
Phylogenetic placement of putative recombinant genome regions. Phylogenetic reconstruction of 474 
2000 samples chosen to be representative of the course of the epidemic in the UK, as well as the 16 475 
recombinant genomes, with their B.1.1.7-like part (coloured triangles) and non-B.1.1.7-like part 476 
(coloured circles) alternately unmasked. 477 
 478 
Figure 4 479 
Mosaicism of putative recombinants. Recombinant groups A-D contain multiple sequences 480 







B.1.1.7 are shown in blue, whilst virus genome regions matching other lineages are shown in yellow. 482 
Gaps represent ambiguity in the exact position of the recombinant breakpoints; there are no lineage-483 
defining mutations within these regions. The breakpoint coordinates are taken from Table 1. 484 
 485 
Figure 5 486 
The community transmission of Group A. A) The phylogenetic relationships between the closest 487 
genetic neighbours of Group A for the B.1.1.7-inherited region of their genome (top clade; left-hand 488 
tree), and the B.1.177-inherited region of their genome (bottom clade; left-hand tree), with branch 489 
lengths scaled by time. The sample date in cumulative epidemiological weeks (epiweeks) since the 490 
first epiweek of 2020 for each sequence is also represented by coloured circles at the tips of each tree. 491 
The closest two parental sequences by genetic similarity for the two regions of the genomes (ALDP-492 
12A277F and ALDP-119C5F7) are labelled in the left-hand tree and their tips are highlighted by 493 
black rings. The phylogenetic relationships within Group A (top four taxa) and their descendants 494 
(bottom 41 taxa) are shown in the right-hand tree, with branch lengths scaled by divergence. The 495 
dashed lines represent the formation of a new recombinant clade between the members of Group A 496 
and their parental lineages. B) The geographic context of the transmitted recombinant sequences. The 497 
exploded region of the map is the North West region of England. All of the 41 recombinants 498 
descended from Group A were sampled in this region. The relative distribution of their locations, in 499 
the same scale as the exploded region, are represented by the circles in the red dashed square. The size 500 
of the points represents the number of genomes sequenced in each location. The absolute locations of 501 
the recombinants within North West England are not represented by this panel. C) The distribution of 502 
the sampling dates for the 45 recombinants, aggregated by epiweek. Orange bars: the four original 503 












Table 1 509 
 510 
Recombinants and their putative second parental lineages according to genetic similarity (the first 511 
parental lineage is always B.1.1.7). For the recombinant groups the number of genomes, the NUTS1 512 
location of residence and the range of sampling dates are given. Breakpoint coordinates are the range 513 
of possible SARS-CoV-2 genome positions bounded by mutations that are unambiguously inherited 514 
from one parent or the other, including both single nucleotide polymorphisms and deletions. The date 515 
and location for the 2nd parent is for the genetically most similar UK genome(s) within the genome 516 
region belonging to that lineage. 517 
 518 
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B.1.36.28 2020/12/10 Greater 
London 
6528 – 6954 































2020/12/18 B.1.177 2020/12/12 Greater 
London 
3267 – 6286 













2021/01/12 B.1.177.16 2020/12/14 Greater 






1 Scotland 2021/01/17 B.1.177.9 2021/01/13 Greater 
London 
















Table 2  531 
 532 
Recombinants, their putative second parental lineages, and inferred breakpoints according to 3SEQ 533 
(the first parental lineage is always B.1.1.7). P-values for the Δm,n,2 statistic are reported uncorrected, 534 
and after Dunn-Sidak correction for multiple comparisons.  535 
 536 
a
 The breakpoint coordinates reported by 3SEQ are the positions of spaces between nucleotides. 537 
b
 For Group A, the results for LIVE-DFCFFE (in parentheses) were different to those of the rest of the 538 
group. 539 
c
 Statistics are from a separate run with the closest neighbours by genetic similarity included in the 540 





lineage Uncorrected p-value Corrected p-value Breakpoint coordinatesa 




   5.70E-07 1 6528 – 6953 
Group C B.1.221.1 4.26E-10 0.02686 25996 – 27441 
Group D B.1.36.39 3E-12 0.0002 20703 – 23062 
CAMC-CBA018 B.1.177 2E-12 0.00014 20389 – 21254 
CAMC-CB7AB3 B.1.177 1E-11 0.00065 3267 – 4474 & 20389 – 
21254 
MILK-103C712 B.1.177.17 1.06E-10 0.00673 408 – 444 & 26801 – 
27876 
QEUH-1067DEF B.1.177.9 4.12E-10 0.026 
  
10523 – 10869 
 544 








Supplemental Figure Titles and Legends 546 
 547 
Figure S1. Read data minor allele frequencies. (See STAR Methods) 548 
The distribution of minor allele frequencies from the read data for the 16 putative recombinants (red 549 
bars) and 20 samples suspected of being sequenced mixtures, either due to co-infection or laboratory 550 
contamination (grey bars). For each recombinant, the minor allele frequency is the mean across all 551 
sites that differ by a nucleotide change from the reference (MN908947.3) in it or either of its putative 552 
parentals by genetic similarity. For the mixtures, the minor allele frequency is the mean across the 553 
sites that differ by a nucleotide change from the reference at genomic positions where mutations occur 554 
in B.1.1.7. 555 
 556 
Figure S2. The nucleotide variation present in the recombinants and their parentals. (Related to 557 
Figure 2). 558 
The nucleotide variation with respect to the reference sequence (MN908947.3; grey genome far 559 
bottom) for each of the recombinant genomes (middle coloured genomes in each panel) and their 560 
closest neighbours by genetic similarity among all UK sequences from the same time period, for the 561 
B.1.1.7-like and non-B.1.1.7-like regions of their genomes (top and bottom coloured genomes in each 562 
panel). Panels: A) Group B; B) Group C; C) Group D; D) CAMC-CBA018; E) CAMC-CB7AB3; F) 563 
MILK-103C712; G) QEUH-1067DEF. 564 
 565 
Figure S3. SARS-CoV-2 lineages in geographic regions of the UK relevant to the recombinants. 566 
(Related to Figure 1). 567 
The distribution of the most frequent SARS-CoV-2 lineages in the NUTS1 location of each set 568 
(Groups A-D and the four singletons) of recombinants for the four weeks immediately preceding each 569 
set’s (earliest) sample date. Here, B.1.177 refers to B.1.177 itself and all its descendant lineages (e.g. 570 









Figure S4. The nucleotide variation present in the descendants of Group A. (See also Figure 5) 573 
The distribution of nucleotide variation in the original members of Group A (top four coloured rows) 574 
and the 41 additional sequences that are derived from it (bottom 41 coloured rows), with respect to the 575 
reference sequence (MN908947.3; very bottom grey sequence). 576 








STAR METHODS 578 
 579 
RESOURCE AVAILABILITY 580 
Lead Contact 581 
Further information and requests for resources and reagents should be directed to and will be fulfilled 582 
by the Lead Contact, Ben.Jackson@ed.ac.uk 583 
 584 
Materials Availability  585 
This study did not generate new unique reagents. 586 
 587 
Data and code availability 588 





METHOD DETAILS 594 
 595 
Identification of putative recombinants 596 
A national SARS-CoV-2 sequencing effort in the UK, the COG-UK consortium (COVID-19 597 
Genomics UK (COG-UK) consortiumcontact@cogconsortium.uk, 2020), has undertaken systematic 598 
genomic surveillance of SARS-CoV-2 in the country and generated over 440,000 genomes to date. As 599 
part of the COG-UK daily analytical pipeline (https://github.com/COG-UK/grapevine_nextflow), the 600 
consensus genome sequences of the complete set of UK samples were aligned to the SARS-CoV-2 601 
reference sequence (Genbank accession: MN908947.3) using Minimap2 (Li, 2018). The aligned 602 
sequences were converted from sam to fasta format, and each assigned a Pango lineage (Rambaut et 603 








epidemiological trends at a resolution suitable for genomic epidemiology and outbreak investigation 605 
(Rambaut et al., 2020). From the sequence alignment, we extracted all sequences that had been 606 
assigned to lineage B.1.1.7, up to the 2021/03/07. We genotyped these sequences at the set of 22 sites 607 
that discriminate B.1.1.7 from its parental lineage (B.1.1) using a custom script in Python 608 
(https://github.com/cov-ert/type_variants), then discarded sequences with missing data at any of the 609 
22 sites. We visualised the resulting table of genotype calls in order to identify sequences that showed 610 
evidence of a potential mosaic genome structure (i.e. runs of contiguous sites that were not compatible 611 
with the B.1.1.7 lineage designation). 612 
 613 
 614 
Identification of candidate parental sequences 615 
To identify candidate parental genome sequences in a computationally-tractable manner we created a 616 
set of all UK SARS-CoV-2 sequences that (i) contained no N nucleotide ambiguity codes after 617 
masking the 3’ and 5’ UTRs, (ii) spanned the dates 2020/12/01 to 2021/02/28, which represents two 618 
weeks before the date of the earliest putative recombinant, to one week after the date of the latest, and 619 
(iii) excluded the putative recombinant genomes identified above. This set consisted of 98859 620 
sequences in total. For each putative recombinant, we split its genome sequence into B.1.1.7-like 621 
regions and non-B.1.1.7 regions at the junction of genetic regions according to the mosaic structure 622 
detected by the custom Python script described above (https://github.com/cov-ert/type_variants; 623 
Supplementary Table S1). Then for each component region of each mosaic genome, we first masked 624 
the remainder of the genome with Ns (in both the focal mosaic sequence and all background 625 
sequences) then found the most-genetically similar non-focal sequences by computing pairwise 626 
genetic distances (number of nucleotide differences per site) using gofasta (https://github.com/cov-627 
ert/gofasta). Subsequently, an alignment was compiled for each putative recombinant, which 628 
contained the putative recombinant as well as the most-genetically similar background sequences (as 629 
identified above) for each component region of that mosaic genome. The single nucleotide differences 630 
between the putative recombinant and the closely related reference sequences were visualised using 631 








mosaic genome region were then refined by taking into account observed lineage-defining nucleotide 633 
and deletion variation. Specifically, we set the boundary coordinates to the ends of sequential tracts of 634 
mutations specific to the putative parental sequences. This is a conservative approach to assigning 635 
parental lineages and consequently no parental lineage is assigned to those genome regions that do not 636 
contain unambiguous lineage-defining mutations or deletions. Lastly, using these refined region 637 
boundaries, we reiterated the genetic distance calculation above to identify a final set of most-638 
genetically similar sequences for each putative recombinant. 639 
 640 
When reporting geographic locations for UK virus genome sequences we use level 1 of the 641 




Defining a representative sample from the UK epidemic 646 
To generate a limited set of genomes that are suitable for computationally-expensive analysis yet are 647 
also representative of the genetic diversity of the SARS-CoV-2 epidemic in the UK, we randomly 648 
sampled 2000 sequences from 21st March 2020, when sequence data first became available, to 1st 649 
March 2021, weighting the probability of choosing a sequence accounting for the sequencing 650 
coverage and covid19 prevalence in individual geographic regions of the UK over time, using the 651 
same method as in Volz et al. (2021), which is available at 652 
(https://github.com/robj411/sequencing_coverage). We use this dataset to investigate the phylogenetic 653 
placement of the alternate regions of recombinant genomes, and as a dataset of putative parental 654 
sequences to statistically test for recombination using 3SEQ. 655 
 656 
 657 
Investigation of read data 658 
Almost all sequencing sites in the COG-UK consortium use the ARTIC PCR protocol to produce tiled 659 








then processed using sequence mapping, rather than sequence assembly, to produce a consensus 661 
genome for each sample. This approach, which was designed to support epidemiological 662 
investigations, creates a single consensus sequence for each sample. Beyond representing sites with 663 
high minor allele frequencies using the appropriate IUPAC nucleotide alphabet ambiguity code, this 664 
consensus does not reflect the natural genetic variation of SARS-CoV-2 genomes observed within an 665 
infected individual (Lythgoe et al., 2021). Mapping is particularly suited to tiled amplicons generated 666 
from samples that contain limited genomic diversity. Further, mapping is typically less prone to 667 
introducing errors/artefacts than sequence assembly and enables effective primer sequence removal 668 
and identification of non-reference mutations. Genomic sites that exhibit intra-sample nucleotide 669 
variation could be consistent with a range of processes, including co-infection, within-patient 670 
diversity, contamination, or PCR error. The identification of such sites forms part of the consensus-671 
generating pipeline, and we exploit that information here in order to rule out the possibility that our 672 
mosaic consensus sequence represents a mixture of virus genomes, rather than representing true 673 
recombinant genomes. 674 
  675 
For each putative recombinant sequence we analysed the original read data from virus genome 676 
sequencing in order to rule out the possibility that the generated consensus sequence represents a 677 
mixture of virus genomes (due to laboratory contamination or coinfection, for example), rather than 678 
representing a true recombinant genome. To do this we calculated minor allele frequencies (MAFs) 679 
from the read data and compared their distribution between the 16 recombinant genomes and 20 680 
samples that we suspected of being the product of sequencing a mixture of genomes, potentially 681 
because of coinfection or laboratory contamination. To define sequences that we suspected of being 682 
mixtures, we scanned the dataset for consensus sequences that possessed an IUPAC ambiguity code at 683 
the 27 genomic positions that differ from the SARS-CoV-2 reference genome (Genbank accession: 684 
MN908947.3) by a nucleotide change in B.1.1.7 (the 27 positions include those with nucleotide 685 
changes that were inherited from the ancestor of B.1.1.7). We define the MAF at a single site as the 686 
number of sequencing reads not containing the most frequently observed single nucleotide allele that 687 








that mapped to that site. For each virus genome, we defined a set of genomic positions from which to 689 
calculate MAF as follows. For each recombinant, we considered every site that differed from 690 
MN908947.3 by a nucleotide in its own consensus genome, or in the consensus genome of either of 691 
its parentals by genetic similarity. For the sequences that we suspected of being mixtures we 692 
considered the 27 genomic positions where sequences belonging to B.1.1.7 differ from MN908947.3 693 
by a nucleotide change. We used samtools (Li et al., 2009), with default filters for mapping and base 694 
quality, to extract allele calls from the read data using its mpileup subroutine, and to calculate mean 695 
read depth per genome using its depth subroutine.  696 
 697 
 698 
QUANTIFICATION AND STATISTICAL ANALYSIS 699 
 700 
Test for mosaic genome structure 701 
We used 3SEQ (Lam, Ratmann and Boni, 2018) as a statistical test for recombination in the UK 702 
SARS-CoV-2 data. 3SEQ interrogates triplets of sequences for a signal of mosaicism in one “child” 703 
sequence, given the genotypes of the other two “parental” sequences, using an exact non-parametric 704 
test for clustering in a sequence of binary outcomes (Boni, Posada and Feldman, 2007). The test 705 
statistic Δm,n,2  used in 3SEQ simply tests if a putative recombinant’s ancestry in parental A clusters in 706 
the middle of the genome, while ancestry in parental B clusters in the outer regions of the genome. 707 
We manually adjusted two-breakpoint recombinants to be single-breakpoint recombinants if one of 708 
the breakpoints according to 3SEQ abutted the beginning or end of the genome. We tested all 709 
potential pairs of sequences from the representative parental dataset from the course of the UK 710 
pandemic (n = 2000) against each putative recombinant in the child dataset (n = 16), and report p-711 
values that are uncorrected and that are Dunn-Sidak corrected for multiple comparisons (n = 64.0 712 
million). We performed a single additional run of 3SEQ with two putative recombinant sequences that 713 
were not found to be significantly the mosaic product of any of the sequences in the representative 714 
background as children, and their closest neighbours by genetic similarity as parentals. P-values for 715 








test was in addition to the 64 million comparisons that we had already performed. The input and 717 




Test for the phylogenetic incongruence of putative recombinant genome tracts 722 
For each of the eight sets of recombinants (Groups A-D and the four singletons) we carried out the 723 
following procedure to test for incongruence between the phylogenetic placements of the two regions 724 
of their genomes. We independently added each set’s genome(s) to the representative background of 725 
2000 sequences, along with the reference sequence, to create eight alignments in total. We masked the 726 
resulting alignments according to the breakpoints defined by the closest neighbours by genetic 727 
similarity, so that for each set, we produced two sub-alignments: one consisting of the region that was 728 
inherited from the B.1.1.7 parental in the recombinant(s), and one consisting of the region that was 729 
inherited from the other parental. This resulted in 16 alignments in total. We reconstructed the 730 
phylogenetic relationships for each with IQTREE v2.1 (Minh et al., 2020), using the HKY model of 731 
nucleotide substitution, conducting 1000 ultrafast bootstrap replicates (Minh, Nguyen and von 732 
Haeseler, 2013; Hoang et al., 2018), and rooting the tree on the reference sequence, which is basal to 733 
all B lineage sequences. The phylogenetic trees produced by this analysis are available at 734 
https://github.com/COG-UK/UK-recombination-analysis. 735 
 736 
To determine the placement of the different regions of each recombinant genome in a single context, 737 
we also built a phylogenetic tree of the representative background’s complete genomes, to which we 738 
added the masked recombinant genomes, so that each recombinant was present in the alignment 739 
twice, once with the B.1.1.7 region of its genome unmasked, and once with the opposing region 740 
unmasked. We ran IQTREE as above.  741 
 742 
 743 








To test for onward community transmission of the putative recombinants, we searched the whole UK 745 
dataset as of the 5th May 2021 for additional sequences whose genetic variation matched the variation 746 
of the recombinants. For each of the eight set of recombinants, we defined a set of SNPs and deletions 747 
by which all the recombinants within that set differed from the reference sequence (MN908947.3). 748 
Then we used type_variants to scan the UK dataset for genomes whose SNP and deletion variation 749 
was compatible with being a descendant or sibling of the putative recombinants. Group A represented 750 
the only recombination event with evidence for further transmission according to the results of this 751 
procedure. We carried out the following additional analyses to further investigate transmission of 752 
Group A genomes. Firstly, we visualised the nucleotide variation of the additional matching genomes 753 
using snipit and extracted their sampling locations and dates. Secondly, to explore the phylogenetic 754 
context of Group A and its derivatives, we reconstructed their (whole-genome) phylogenetic 755 
relationships using IQTREE. We also extracted the 100 closest sequences by genetic similarity for 756 
each alternate region of the genome (B.1.1.7-like and non-B.1.1.7-like) for each of the four original 757 
members of Group A to provide phylogenetic context to the parental sequences. This resulted in a 758 
dataset of 216 sequences in total when the two groups of neighbours were combined, and duplicates 759 
removed. We reconstructed their (whole-genome) phylogenetic relationships with the IQTREE, as 760 
above. We generated a time-scaled phylogenetic tree from the divergence tree of parental sequences 761 
using TreeTime (Sagulenko et al. 2018), setting the --clock-rate parameter to 0.001. We labelled the 762 
phylogenetic tree of recombinants and the phylogenetic tree of parental sequences with the sampling 763 
date in number of epidemiological weeks (epiweeks) since the first epiweek of 2020 to assess the 764 
temporal context of the recombination event and subsequent transmission.  We carried out a second 765 
follow up on 14
th
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 We find evidence for recombination in SARS-CoV-2 
 We identify 8 clear recombination events 4 of which lead to onward transmission  
 Estimated breakpoints are consistent with coronavirus cellular replication 
dynamics 
 Transmitted recombinants inherited the more-transmissible B.1.1.7 Spike gene 
 
 
Sampling from late 2020 to early 2021 provides evidence for SARS-CoV-2 recombination and onward 
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